Background {#Sec1}
==========

DD/ID refers to a large group of developmental disorders characterized by significant limitations in intellectual functioning and adaptive behaviors \[[@CR1]\]. The onset of DD/ID usually is observed before the age of 18 years. Patients at the age of 5 years or younger who present with reasoning and learning difficulties and motor developmental delay are diagnosed as DD, whereas those who become symptomatic at the age over 5 years are regarded as ID \[[@CR2]\]. DD/ID, with an estimated incidence of 1--3%, can be highly heterogeneous in clinical phenotype and genetic etiology \[[@CR2]\]. About 25--50% DD/ID is associated with genetic alteration, such as 21, 18, or 13 trisomy or submicroscopic deletion/duplication \[[@CR3]\].

CMA is featured by whole genome coverage, high resolution and rapid detection \[[@CR4]\]. It has been recommended as the first-line clinical diagnostic test for individuals with unexplained DD/ID, autism spectrum disorders (ASDs) or multiple congenital anomalies (MCA) \[[@CR5]\]. CMA can not only detect submicroscopic chromosomal imbalances, but also delineate the size and gene content of the detected segment. This is crucial for phenotype/genotype correlation and for identifying candidate genes involved in the development of certain anomalies \[[@CR6]\].

The present case documented the clinical phenotype and genetic analysis of a Chinese family affected by ID using CMA.

Case presentation {#Sec2}
=================

The proband was a 19-year-old pregnant woman who was referred to the department of medical genetics at the hospital for prenatal diagnosis due to a family history of intellectual disability. She was delivered vaginally at full-term. During the neonatal period, she was hypotonic and very passive. Her growth milestones were recalled. She walked at 1 year and 8 months of age, and learned to say "mama" at 2 years. She talked at nearly 3 years and showed severe ID. She began the first period of menstrual at the age of 13 years, and got married at 18 years. She was in pregnancy at 18 weeks' gestation when referred for genetic counseling and prenatal diagnosis. She had facial dysmorphism including a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears (Fig. [1](#Fig1){ref-type="fig"}). Examinations in psychological clinic showed that her height was 154 cm \[0 SD\]; weight was 61 kg \[− 0.2 SD\]; and head circumference was 54 cm \[− 1.12 SD\] \[[@CR7], [@CR8]\]. Her IQ score was 32 as accessed by the Wechsler Adult Intelligence Scale-Revised China (WAIS-RC). In terms of the scale, a score ≤ 75 is considered as low intelligence, and a score of 32 suggests severe ID. Reportedly, she was able to care for herself in daily life. Clinical observation showed that she was introverted; seldom talked; had dementia and social dysfunction without depression and anxiety. Both her electroencephalogram (EEG) and brain MRI result were normal. No history of heart diseases was noted. Her father was reported to have low intelligence, but an on-site examination for her father was not achieved. Her mother was of normal intelligence but had scoliosis. Her paternal grandparents and uncles and the fetus' father had no noticeable congenital anomalies. Fig. 1The pedigree (**a**) of a Chinese family affected by intellectual disability and facial features of the proband (**b**). The facial features of the proband (III-1) included a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears

Written informed consent was obtained from the family (The proband was under the guardianship of her mother). Peripheral blood for each participant and the amniotic fluid of the proband were drawn for genetic testing. Heart rate, blood pressure and electrocardiogram of the proband were monitored before amniocentesis. Conventional G-banded karyotype analysis showed a normal female karyotype (46,XX) in the proband. However, CMA using the CytoScan 750 K Array from Affymetrix (Thermo Fisher Scientific, USA) revealed a 936.3 kb heterozygous deletion of chromosome 1q22 (arr\[GRCh37\] 1q22 (155016052_155952375)×1) in the proband (Fig. [2](#Fig2){ref-type="fig"}). The microdeletion was also detected in the proband's father (II-2) and the fetus (IV-1), but absent in her mother (II-1), grandparents (I-1, I-2) and paternal uncles (II-3, II-4). Other members within the pedigree were not tested. For all tested individuals, no other CNVs were detected except known polymorphisms (frequency \> 1%). Fig. 2The SNP-array results of tested members from the Chinese family affected by intellectual disability. The proband (III-1), her father (II-2) and the fetus (IV-1) all contain a 936.3 kb heterozygous deletion of chromosome 1q22 (arr\[GRCh37\] 1q22 (155016052_155952375)×1). No significant CNVs were identified in the proband's mother (II-1), grandparents (I-1 and -2) and paternal uncle II-3

In search of public databases (Decipher, DGV and ClinVar) and literature, a few cases reported copy number losses of the 1q22 region including *ASH1L* and the associated phenotypes including ID with MCA (Table [1](#Tab1){ref-type="table"}). Furthermore, haploinsufficiency of *ASH1L* is strongly associated with DD/ID and MCA in multiple individual cases \[[@CR9], [@CR10]\]. On the basis of these observations, plus the co-segregation of genotype and phenotype in the current case, the detected CNV is considered to be pathogenic, being in line with the guidelines from the American College of Medical Genetics (ACMG) \[[@CR11]\]. After full consideration, the family chose to terminate the pregnancy. Table 11q22 microdeletions/duplications including *ASH1L* from public databases and literatureDatabase/ LiteratureIndex IDVariantSizeInheritancePhenotype(s)Clinic SignificanceThis report/\[GRCh37\] 1q22 (155016052_155952375)×**1**936.3 KbPaternalIntellectual disability, behavioral problems, forehead, flat face, flat nasal bridge, short upturned nose, thin lips, small ears.PathogenicFaundes et al.^\*^/\[GRCh37\] 1q22 (155271366_155804269)×**1**532.9 KbDe novoIntellectual disability, behavioral problems, cryptorchidism and blocked nasolacrimal duct, microcephaly,/Decipher249,031\[GRCh37\] 1q22 (154292095−155569326)×11.28 MbDe novoDelayed speech and language development, hypertelorism, intellectual disability, long face, low-set earsUnknownDecipher255,240\[GRCh37\] 1q22 (155192986_156108069)×**1**915.08 KbUnknownBroad nasal tip, delayed speech and language development, dental malocclusion, intellectual disability, low-set ears, malar flattening, narrow palate, nasal speech, posteriorly rotated earsUnknownDecipher359,103\[GRCh37\] 1q22 (154687479_156014014)×11.33 MbDe novoAbnormality of the nervous system, autism, scoliosisLikelypathogenicDGVesv33869\[GRCh37\] 1q22 (155223283_155917961)×**1**694.6Kb///DGVdgv3n68\[GRCh37\] 1q22 (155094978_155313409)×1218.4 Kb///ClinVarVCV000659609.1\[GRCh37\] 1q22 (155294636_155452240)×**1**157.6Kb//PathogenicDecipher251,442\[GRCh37\] 1q22 (155264908_156495512)×**3**1.23 MbInheritedCryptorchidism, delayed speech and language development, intellectual disability, strabismusUnknownClinVarVCV000253835.1\[GRCh37\] 1q22 (155412745_155755215)×**3**342.47 kb/Attention deficit hyperactivity disorderUncertainSelected deletion/duplication cases are listed. "/", information not provided; "\*", reference \[[@CR9]\]

Discussion {#Sec3}
==========

The identified microdeletion in the proband involves 43 known genes, of which 24 were OMIM genes, including *ADAM15* (OMIM: 605548), *EFNA4* (OMIM: 601380), *EFNA3* (OMIM: 601381), *EFNA1* (OMIM: 191164), *SLC50A1* (OMIM: 613683), *DPM3* (OMIM: 605951), *TRIM46* (OMIM: 600986), *MUC1* (OMIM: 158340), *THBS3* (OMIM: 188062), *MTX1* (OMIM: 600605), *GBA* (OMIM: 606463), *SCAMP3*(OMIM: 606913), *CLK2* (OMIM: 602989), *HCN3*(OMIM: 609973), *PKLR* (OMIM: 609712), *FDPS* (OMIM: 134629), *ASH1L* (OMIM: 607999), *YY1AP1* (OMIM: 607860), *DAP3* (OMIM: 602074), *GON4L* (OMIM: 610393), *SYT11* (OMIM: 608741), *RIT1* (OMIM: 609591), *RXFP4* (OMIM: 609043), and *ARHGEF2* (OMIM: 607560). Among these OMIM genes, *TRIM46*, *CLK2*, *ASH1L*, *GON4L* and *ARHGEF2* are marked by a high probability of being loss of function intolerant (pLI ≥ 0.9), in contrast to other genes with a moderate (*RIT1* pLI: 0.67) or low probability. Therefore, haploinsufficiency of the genes with high pLI is particularly concerned. In OMIM database, the phenotypes of heterozygous loss of *TRIM46*, *CLK2*, *GON4L* and *ARHGEF2* in humans have not been fully documented, whereas a handful of individual patients featured by intellectual disability are reported to carry a heterozygous nonsense or frame-shift mutation of *ASH1L*, which results in truncated and nonfunctional protein \[[@CR12]--[@CR14]\]. The documented cases highly support that alteration in gene dosage of *ASH1L* is associated with neurodevelopmental disorders. In more recent studies, additional de novo loss of function variants of *ASH1L* have been identified, and all patients presented with mild to severe DD/ID \[[@CR10]\]. Interestingly, a 532.9 kb heterozygous deletion (arr\[GRCh37\] 1q22 (155271366_155804269)×1) was found in a 7-year-old boy who had microcephaly and severe ID with MCA \[[@CR9], [@CR10]\]. Notably, the microdeletion identified in the present case fully encompasses the 532.9 kb segment and involves more OMIM genes. Based on these observations, the 1q22 microdeletion of 936.3 Kb including *ASH1L* is regarded as pathogenic and associated with ID. Importantly, not only micro-deletions, but also duplications within 1q22 may cause neurodevelopmental abnormalities (Table [1](#Tab1){ref-type="table"}).

Though the pathogenicity of *ASH1L* haploinsufficiency is evident, contribution of other OMIM genes (e.g. *CLK2*, *ARHGEF2* and *RIT1*) to the phenotypes in this case cannot be fully excluded \[[@CR15]--[@CR17]\]. It is noteworthy that some clinical features of the proband resemble certain phenotypes such as broad forehead, broad nasal bridge, and learning/intellectual disabilities described in Noonan syndrome (NS), an autosomal-dominant disorder \[[@CR15]\]. In a more recent report on the molecular and phenotypic spectrum of a Chinese NS cohort (*n* = 103), 6 out of 7 patients with *RIT1* mutation presented with various congenital heart defects, and a high rate (4 out of 7) of hypertrophic cardiomyopathy was observed in *RIT1* mutation-positive patients \[[@CR18]\]. With regard to the proband in this report, although cardiac imaging examination was not performed, heart rate, blood pressure and electrocardiogram were recorded prior to ultrasound-guided amniocentesis. The normal readouts plus no previous history of heart disease suggested that it was unlikely that the patient had cardiomyopathy. Taking the potential involvement of multiple functional genes into account, it remains to be further elucidated whether this 1q22 microdeletion causes contiguous gene syndrome.

*ASH1L* encodes a histone lysine methyltransferase that catalyzes mono- and di-methylation of histone 3 lysine 36 (H3K36). This gene is highly expressed in both embryonic and adult human brains \[[@CR19]\]. An inadequate amount of ASH1L protein due to copy number loss of the gene may affect epigenetic regulation of the expression program involved in embryo and brain development. Animal model studies show that mice in homozygosity of a hypomorphic *ASH1L* allele exhibited growth insufficiency, skeletal transformations and impaired fertility associated with developmental defects of reproductive organs \[[@CR20]\]. In this case, the 1q22 microdeletion including *ASH1L* resulted from a de novo mutation in the proband's father. Phenotipically, both the proband and her father were fertile, suggesting that haploinsufficiency of *ASH1L* may not cause infertility in humans.

In summary, the present case shows the clinical phenotype of the proband in a Chinese family affected by ID and identification of a 1q22 microdeletion including *ASH1L* as the genetic cause in the pedigree. This case broadens the spectrum of ID-related CNVs and may be useful as a reference for clinicians. Apart from clinical findings, certain social and ethic issues also are brought into our sight by the case. For instance, was the pregnancy of the proband's own free will? How should the fate of the fetus be decided? Though it may take time to find out the best solutions for the scenario resembling the case, there is no doubt that more social care is demanded with regard to women patients with intellectual disability.
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